Kwivik Therapeutics is a pre-IPO medtech leader with a robust pipeline of novel products for respiratory, emergency medical, asthma, cluster headache/migraine, wound care and skin care markets. Our patent protected methodologies combine innovative biotech, engineering, IoT and IA technologies to create category killers in multiple mega markets in the therapeutics, emergency medical, and pandemic preparedness sectors globally.